- Home
- Publications
- Publication Search
- Publication Details
Title
Current Role of Functional Imaging in the Management of Lymphoma
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 23, Issue 12, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-04
DOI
10.1007/s11912-021-01127-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baseline SUVmax did not predict histological transformation in the phase 3 GALLIUM study in follicular lymphoma
- (2020) Farheen Mir et al. BLOOD
- Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results from the CALGB 50303 Clinical Trial
- (2020) Heiko Schöder et al. BLOOD
- Predicting the future for DLBCL
- (2020) Bruce D. Cheson BLOOD
- ΔSUVmax for interim PET in DLBCL: old is new
- (2020) Michel Meignan et al. BLOOD
- FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study
- (2020) N. George Mikhaeel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET ‐adapted strategy
- (2020) Simonetta Viviani et al. HEMATOLOGICAL ONCOLOGY
- Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful ?
- (2020) Sally F Barrington et al. JOURNAL OF NUCLEAR MEDICINE
- Deep learning FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma
- (2020) Nicolò Capobianco et al. JOURNAL OF NUCLEAR MEDICINE
- Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma
- (2020) Fatima-Zohra Mokrane et al. RADIOLOGY
- Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA
- (2020) Sarah C. Rutherford et al. Blood Advances
- Long-Term Results of PET-Guided Radiation in Advanced-Stage Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
- (2020) Ciara L. Freeman et al. BLOOD
- Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.
- (2020) Paul Blanc-Durand et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial
- (2020) Emanuele Zucca et al. HEMATOLOGICAL ONCOLOGY
- Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT†
- (2020) A.-S. Cottereau et al. ANNALS OF ONCOLOGY
- Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA
- (2020) Steven Le Gouill et al. BLOOD
- PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
- (2019) René-Olivier Casasnovas et al. LANCET ONCOLOGY
- A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
- (2019) Sarah A. Milgrom et al. Scientific Reports
- Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio
- (2019) Mathieu N. Toledano et al. PLoS One
- Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study
- (2019) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI.
- (2019) M. Federico et al. HEMATOLOGICAL ONCOLOGY
- 18F-FDG-PET dissemination features in diffuse large B cell lymphoma are prognostic of outcome
- (2019) Anne-Segolene Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo
- (2019) Yvonne Jauw et al. JOURNAL OF NUCLEAR MEDICINE
- MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial
- (2019) Christiane Pott et al. LEUKEMIA
- Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study
- (2018) Anne Ségolène Cottereau et al. BLOOD
- Speaking volumes about volumes
- (2018) Bruce D. Cheson BLOOD
- Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma
- (2018) Luca Ceriani et al. BLOOD
- FDG-PET in PMBCL: which heterogeneity?
- (2018) Michel Meignan et al. BLOOD
- Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study
- (2018) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine
- (2018) Mark P. S. Dunphy et al. RADIOLOGY
- CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET
- (2018) David J. Straus et al. BLOOD
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
- (2018) David M. Kurtz et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial
- (2018) Judith Trotman et al. LANCET ONCOLOGY
- Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry
- (2018) Ur Metser et al. RADIOLOGY
- Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
- (2017) Marc P.E. André et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
- (2017) Anne-Ségolène Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
- (2017) Robert Marcus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
- (2016) Bruce D. Cheson et al. BLOOD
- PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study
- (2016) S. F. Barrington et al. BLOOD
- Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma
- (2016) A.-S. Cottereau et al. CLINICAL CANCER RESEARCH
- Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
- (2016) N. George Mikhaeel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Biological correlation between glucose transporters, Ki-67 and 2-deoxy-2-[18F]-fluoro-D-glucose uptake in diffuse large B-cell lymphoma and natural killer/T-cell lymphoma
- (2016) Y.M. Liu et al. GENETICS AND MOLECULAR RESEARCH
- Interim Positron Emission Tomography Response–Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study
- (2016) Pier Luigi Zinzani et al. JOURNAL OF CLINICAL ONCOLOGY
- US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816
- (2016) Oliver W. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
- (2016) Michel Meignan et al. JOURNAL OF CLINICAL ONCOLOGY
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
- (2016) Peter Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma
- (2016) Maria Rosana Ponisio et al. PEDIATRIC RADIOLOGY
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
- (2016) F. Scherer et al. Science Translational Medicine
- The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
- (2016) Claudio Agostinelli et al. Lancet Haematology
- Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
- (2015) L. Ceriani et al. BLOOD
- FDG PET/CT imaging as a biomarker in lymphoma
- (2015) Michel Meignan et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi
- (2015) S. Luminari et al. HAEMATOLOGICA
- Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma
- (2015) H. Schoder et al. JOURNAL OF NUCLEAR MEDICINE
- Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
- (2015) John Radford et al. NEW ENGLAND JOURNAL OF MEDICINE
- Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi
- (2015) S. Luminari et al. HAEMATOLOGICA
- Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cells
- (2014) Michel Meignan EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
- (2014) A. Gallamini et al. HAEMATOLOGICA
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Utility of Routine Post-Therapy Surveillance Imaging in Diffuse Large B-Cell Lymphoma
- (2014) Carrie A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
- (2014) Judith Trotman et al. Lancet Haematology
- An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
- (2013) Emmanuel Itti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3–5 October 2012
- (2013) Michel Meignan et al. LEUKEMIA & LYMPHOMA
- Hodgkin Lymphoma: Protecting the Victims of Our Success
- (2012) Bruce D. Cheson JOURNAL OF CLINICAL ONCOLOGY
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
- (2012) Andreas Engert et al. LANCET
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
- (2011) R.-O. Casasnovas et al. BLOOD
- Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
- (2010) Craig H. Moskowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
- (2009) E. Itti et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
- (2009) M. Weiler-Sagie et al. JOURNAL OF NUCLEAR MEDICINE
- Impact of [18F] Fluorodeoxyglucose Positron Emission Tomography on Staging and Management of Early-Stage Follicular Non-Hodgkin Lymphoma
- (2008) Andrew Wirth et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now